After starting 2024 strong, Eli Lilly (NYSE: LLY) did not perform well in the second half of last year. Its financial results, though solid compared to similarly sized peers, were not always up to …
1 Growth Stock With Major Catalysts on the Way to Buy and Hold
view original post